Sponsor Pipeline

Ottimo Pharma Limited Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
Active Trials by Phase
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT07266428 A Study of OTP-01, a Dual Paratopic PD-1/VEGFR2 Antibody, in Patients With Advanced Solid… Advanced Solid Tumors Recruiting
Get alerts when Ottimo Pharma Limited's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free